Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Udo Oppermann

Showing results (161-170 of 209) with videos related to

Pageof 21
Sort By:
Chemico-Biological Interactions|November 26, 2008
The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiativeBengt Persson, Yvonne Kallberg, James E Bray, et al.
Angewandte Chemie (International Ed. in English)|January 14, 2012
Linking of 2-oxoglutarate and substrate binding sites enables potent and highly selective inhibition of JmjC histone demethylasesEsther C Y Woon, Anthony Tumber, Akane Kawamura, et al.
Pathology|March 12, 2019
Role of protein structure in variant annotation: structural insight of mutations causing 6-pyruvoyl-tetrahydropterin synthase deficiencyJoao R C Muniz, Natalie Wing-Sum Szeto, Rebecca Frise, et al.
Nature Communications|September 15, 2016
The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathwayMélissa Carbonneau, Laurence M Gagné, Marie-Eve Lalonde, et al.
Plos One|December 3, 2010
Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitorsOliver N F King, Xuan Shirley Li, Masaaki Sakurai, et al.
Nature Communications|August 25, 2022
Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistanceMark A Tye, N Connor Payne, Catrine Johansson, et al.
Nature|June 26, 2007
Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificityStanley S Ng, Kathryn L Kavanagh, Michael A McDonough, et al.
Journal of Medicinal Chemistry|May 17, 2018
Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular ActivityShyh-Ming Yang, Natalia J Martinez, Adam Yasgar, et al.
Cancers|January 8, 2023
Prospective Assessment of Tumour Burden and Bone Disease in Plasma Cell Dyscrasias Using DW-MRI and Exploratory Bone BiomarkersGaurav Agarwal, Guido Nador, Sherin Varghese, et al.
European Journal of Haematology|December 20, 2023
Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccinationClement Twumasi, Sally Moore, Ross Sadler, et al.
Pageof 21

Showing results (161-170 of 209) with videos related to

Sort By:
Pageof 21
Chemico-Biological Interactions|November 26, 2008
The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiativeBengt Persson, Yvonne Kallberg, James E Bray, et al.
Angewandte Chemie (International Ed. in English)|January 14, 2012
Linking of 2-oxoglutarate and substrate binding sites enables potent and highly selective inhibition of JmjC histone demethylasesEsther C Y Woon, Anthony Tumber, Akane Kawamura, et al.
Pathology|March 12, 2019
Role of protein structure in variant annotation: structural insight of mutations causing 6-pyruvoyl-tetrahydropterin synthase deficiencyJoao R C Muniz, Natalie Wing-Sum Szeto, Rebecca Frise, et al.
Nature Communications|September 15, 2016
The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathwayMélissa Carbonneau, Laurence M Gagné, Marie-Eve Lalonde, et al.
Plos One|December 3, 2010
Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitorsOliver N F King, Xuan Shirley Li, Masaaki Sakurai, et al.
Nature Communications|August 25, 2022
Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistanceMark A Tye, N Connor Payne, Catrine Johansson, et al.
Nature|June 26, 2007
Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificityStanley S Ng, Kathryn L Kavanagh, Michael A McDonough, et al.
Journal of Medicinal Chemistry|May 17, 2018
Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular ActivityShyh-Ming Yang, Natalia J Martinez, Adam Yasgar, et al.
Cancers|January 8, 2023
Prospective Assessment of Tumour Burden and Bone Disease in Plasma Cell Dyscrasias Using DW-MRI and Exploratory Bone BiomarkersGaurav Agarwal, Guido Nador, Sherin Varghese, et al.
European Journal of Haematology|December 20, 2023
Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccinationClement Twumasi, Sally Moore, Ross Sadler, et al.
Pageof 21